
CAS 1186651-51-3
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
7 produits concernés.
Sunitinib Amide (5-[(Z)-(5-Fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide)
CAS :Lactams, nesoiFormule :C16H14FN3O2Couleur et forme :Pale Yellow Yellow PowderMasse moléculaire :299.107Sunitinib Impurity 28
CAS :Formule :C16H14FN3O2Couleur et forme :Yellow SolidMasse moléculaire :299.31(Z)-5-((5-Fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide
CAS :(Z)-5-((5-Fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamideDegré de pureté :98%Masse moléculaire :299.30g/mol(Z)-5-((5-Fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide
CAS :Degré de pureté :98%Masse moléculaire :299.304992675781255-[(Z)-(5-Fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
CAS :Produit contrôléFormule :C16H14FN3O2Couleur et forme :NeatMasse moléculaire :299.305-[(Z)-(5-Fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
CAS :<p>Imatinib is a tyrosine kinase inhibitor that inhibits the activity of ATP-binding cassette subfamily B member 1, a protein involved in the regulation of cellular proliferation and differentiation. Imatinib binds to the ATP-binding site and blocks access to ATP, preventing the generation of phosphorylation, which is necessary for DNA synthesis and cell division. Imatinib has been shown to be effective against chronic myeloid leukemia (CML) by inhibiting the activity of the bcr-abl protein. However, imatinib also inhibits other proteins that are not associated with cancer, such as stem cell factor and cell factor. This drug has been shown to have potential for repositioning in cancer therapy due to its ability to inhibit growth factors that promote tumorigenesis.</p>Formule :C16H14FN3O2Degré de pureté :Min. 95%Masse moléculaire :299.3 g/mol







